SEC Tracker
Get the app

CRISPR Therapeutics CRSP

Samarth Kulkarni sells shares

Samarth Kulkarni, insider filing for CRSP

Form
4
Filed
Importance
Routine
  1. Oct 13, 2026: 8,333 shares acquired
  2. Oct 14, 2026: 4,098 shares sold
  3. Shares owned after transaction: 259,736

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when CRISPR Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
  2. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Merus MRUS
  5. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025